These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3763446)

  • 21. Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma.
    Pavelic ZP; Dave S; Bialkowski S; Priore RL; Greco WR
    Cancer Res; 1980 Dec; 40(12):4617-21. PubMed ID: 7438095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibitory effect of arginine butyrate on the development of Crocker 180/TG tumor in Swiss mice].
    Chany C; Cerutti I
    C R Seances Acad Sci III; 1981 Oct; 293(7):367-9. PubMed ID: 6797689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral effects of Corynebacterium parvum and its effect on the interferon system in mice.
    Kirchner H; Chmielarczyk W; Storch E; Schindler L
    Behring Inst Mitt; 1984 May; (74):183-8. PubMed ID: 6206840
    [No Abstract]   [Full Text] [Related]  

  • 24. Improved survival in severely burned animals using intravenous Corynebacterium parvum vaccine post injury.
    Stinnett JD; Alexander JW; Morris MJ; Dreffer RL; Craycraft TK; Anderson PE; Ogle CK; MacMillan BG
    Surgery; 1981 Feb; 89(2):237-42. PubMed ID: 7455909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of advanced ovarian malignancy with chemoimmunotherapy using autologous tumor and Corynebacterium parvum.
    Gusdon JP; Homesley HD; Jobson VW; Muss HB
    Obstet Gynecol; 1983 Dec; 62(6):728-35. PubMed ID: 6633998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of immunostimulating agents on viral infections.
    Zerial A; Werner GH
    Acta Microbiol Acad Sci Hung; 1981; 28(3):325-37. PubMed ID: 6171144
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline.
    Leahy BC; Honeybourne D; Brear SG; Carroll KB; Thatcher N; Stretton TB
    Eur J Respir Dis; 1985 Jan; 66(1):50-4. PubMed ID: 3979476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunotherapy of mice bearing myeloma and EL4 leukemia].
    Kitasato M
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):958-65. PubMed ID: 2447213
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):379-84. PubMed ID: 7184489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation and fibrinolysis during the infusion of Corynebacterium parvum in man.
    Cederholm-Williams SA; King A; Allington MJ; Gill PG; Sharp AA; Britton BJ
    Br J Cancer; 1978 Jun; 37(6):1074-7. PubMed ID: 678428
    [No Abstract]   [Full Text] [Related]  

  • 31. Antitumor activity of Corynebacterium parvum.
    Milas L; Scott MT
    Adv Cancer Res; 1978; 26():257-306. PubMed ID: 343523
    [No Abstract]   [Full Text] [Related]  

  • 32. Corynebacterium parvum and metastatic breast cancer.
    Haskell CM; Sarna GP; Liu PY
    Br J Cancer; 1982 May; 45(5):794-5. PubMed ID: 7044404
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of the effectiveness and adverse effects of a Corynebacterium parvum vaccine made in Czechoslovakia with Coparvax, a British preparation made by Wellcome, in the treatment of malignant pleural effusions].
    Marel M; Melínová L; Bednár M
    Cas Lek Cesk; 1989 Aug; 128(34):1071-4. PubMed ID: 2790915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coparvax for malignant effusion?
    Drug Ther Bull; 1983 Oct; 21(20):79-80. PubMed ID: 6641514
    [No Abstract]   [Full Text] [Related]  

  • 35. Proliferative glomerulonephritis in mice given intravenous Corynebacterium parvum.
    Uff JS; Mitcheson HD; Pussell BA; Brill M; Castro JE
    J Pathol; 1981 Feb; 133(2):89-105. PubMed ID: 6451676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the combination of Corynebacterium parvum and levamisole on murine tumors.
    Anaclerio A; Conti G; Moras ML; Barale C; Spreafico F
    Eur J Cancer (1965); 1977 Dec; 13(12):1451-53. PubMed ID: 413718
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: Immunological control of cancer.
    Israel L; Edelstein R
    Lancet; 1975 Apr; 1(7913):979-10. PubMed ID: 48154
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of the toxicity of two formulations of Corynebacterium parvum in a double-blind crossover trial in patients with bronchogenic carcinoma.
    Mitcheson HD; Priestman TJ
    Clin Oncol; 1981 Sep; 7(3):179-82. PubMed ID: 7044635
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of Corynebacterium parvum on liver proliferation and regeneration.
    Fisher B; Gebhardt MC; Saffer EA; Fisher ER
    Cancer Res; 1979 Apr; 39(4):1361-8. PubMed ID: 421219
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies of the Corynebacterium parvum-associated anaemia in mice.
    Cox KO; Keast D
    Clin Exp Immunol; 1974 May; 17(1):199-207. PubMed ID: 4466596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.